Authors



Ryan Hungate, DDS, MS

Latest:

AI and the modern optometric practice restart

New systems, digital front desks, and analytics help ODs reinvent practice management plans


Kelly K. Nichols, OD, MPH, PhD, FAAO

Latest:

EyeCon 2022: Co-chairs open with a focus on the future of optometry

Optometry Times' EyeCon co-chairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, MA, OD, FAAO, reflect on the 2023 EyeConversations keynote address, which covered new technology, artificial intelligence, and an update in pharmacology.


Carly Rose, OD, FAAO

Latest:

DED: Developing a 360° diagnosis and treatment plan

Modern technology enables early detection, individualized solutions.


Ehsan Rahimy, MD

Latest:

Achieving improved outcomes through partnerships between optometrists and retina specialists

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Gleb Sukhovolskiy, OD
Gleb Sukhovolskiy, OD

Latest:

MIGS dramatically transforms glaucoma management

Revolutionized treatment offers favorable safety profile, quick postop recovery


Laurel Kelley, OD, FAAO

Latest:

Contact lens disinfection methods still matter

Long-term success of contact lens wearers attributed to education, professional input on cleaning methods



Brad Sutton, OD, FAAO, FORS

Latest:

AAOpt 2022: Genetic testing in AMD

Brad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Genetic testing in AMD: critical, useful, or inappropriate," which he presented during the 2022 American Academy of Optometry meeting.


Erin Rueff, OD, PHD, FAAO

Latest:

AAOpt 2022: Helping astigmatic and presbyopic patients find comfort in their contact lenses

Erin Rueff, OD, PhD, FAAO, shares highlights from her 2022 American Academy of Optometry presentations in the contact lens space.



Raju Kaiti, Moptom

Latest:

Review Duane’s retraction syndrome diagnosis and treatment

Understand the condition’s structural, innervational, neurological, and genetic abnormalities


Erin Melissa Jones, OD

Latest:

Offer patients new contact lens technology: 4 Keys to success

One OD has polished a 4 step process of introducing new contact lens technology to patients


Valerie M. Kattouf, OD, FAAO

Latest:

Pediatric vision and digital media: A bad combination

Research indicates that too much technology usage results in negative effects on eyesight.


Nitish Mehta, MD

Latest:

OCT, OCTA show promise in screening for DR

This imaging technique provides depth-resolved images of retinal vasculature.



Nicole C. Ross, OD

Latest:

Approach patients with low vision on an individual basis

Clinicians must think creatively for solutions to vocational rehabilitation


Birva Shah, OD

Latest:

OCT biomarkers associated with advanced age-related macular degeneration

Imaging can elucidate visual prognosis and disease progression risk.


Kara Rickford, MS

Latest:

Pearls on diagnosing and managing glaucoma for optometrists

Optometrists can play an important role in early detection, earlier surgical referral to experienced skillful surgeons, surveillance, and follow-up care for glaucoma patients.


Micaela Crowley, OD

Latest:

Management of chronic allergic eye disease

Treatment should be adjusted based on disease severity.


Stephen Dellostritto, OD

Latest:

Higher-order aberration correction with scleral lenses

When considering the best modality these lenses' stability are superior.


Rod W. Nowakowski, OD, PhD, FAAO

Latest:

Navigating vision challenges in aviation

Optimizing eye care for pilots is crucial for safe flying.


neena james
Neena James, OD

Latest:

My presbyopia story: How far would your patients go?

Physicians share tales of creative workarounds to cope with this condition.



Paul Smith

Latest:

SECO 2023: Orasis Pharmaceuticals presents pipeline update at OIS

Paul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.


Diana Chu, OD

Latest:

Comanaging tears in Descemet membrane during cataract surgery

Postoperative scenario tracks potential complications.


Kristin O. Chapman, MD

Latest:

The dropless future: SLT as a first-line treatment for glaucoma

Drop tolerance, adherence remain challenges for physicians and patients with glaucoma.


Mike Hennessy Sr, Founder and Chairman, MJH Life Sciences

Latest:

9 months of COVID vaccine innovation

The speed at which the COVID-19 vaccine was developed is the medical breakthrough of our lifetimes.


Oliver Kuhn-Wilken
Oliver Kuhn-Wilken, OD

Latest:

MIGS dramatically transforms glaucoma management

Revolutionized treatment offers favorable safety profile, quick postop recovery


W. Lloyd Clark, MD

Latest:

Achieving improved outcomes through partnerships between optometrists and retina specialists

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.

© 2023 MJH Life Sciences

All rights reserved.